Metsera

Metsera Stock-Based Compensation

Delisted

The Stock-Based Compensation (SBC) of Metsera (MTSR) as of Nov 4, 2026 is 2.39 M USD. In the previous year, Stock-Based Compensation (SBC) was 85,000.00 USD — a change of 2,716.47% (higher).

Stock-Based Compensation

2.39 MUSD

YoY

2,716.47%

Last updated:

Stock-Based Compensation (SBC) of Metsera is 2024 2.39 M USD. Stock-Based Compensation (SBC) of Metsera was 2023 85,000.00 USD. It decreases by 2,716.47% higher compared to the previous year.

The Metsera Stock-Based Compensation history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Stock-Based Compensation
Date
Stock-Based Compensation
Jan 1, 2023
85,000.00 USD
Jan 1, 2024
2.39 M USD
The Metsera Stock-Based Compensation history
YEARStock-Based CompensationYoY
2.39 MUSD+2,716.47%
85,000.00USD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Metsera Stock analysis

What does Metsera do? Metsera Inc. is a clinical stage biopharmaceutical company based in New York City, operating in the Health Care sector with a focus on Biotechnology. The company develops next-generation injectable and oral nutrient stimulated hormone (NuSH) analog peptides for treating obesity and related conditions. Utilizing its proprietary MINT peptide library, HALO half-life extension platform, and MOMENTUM oral delivery system, Metsera has a pipeline including MET-097i, MET-233i, and MET-224o, targeting various obesity treatments with differentiated approaches. Listed on 31 January 2025, the company employs 82 staff. Metsera is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Metsera stock

Stock-Based Compensation (SBC) of Metsera is 2.39 M USD in 2024.

Stock-Based Compensation (SBC) of Metsera changed from 85,000.00 USD to 2.39 M USD, representing a 2,716.47% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Stock-Based Compensation (SBC) Metsera since 2006 – with annual values, charts, and detailed analysis.

Stock-based compensation is a non-cash expense representing equity awards to employees. High SBC can dilute existing shareholders and inflate reported cash flow.

Stock-Based Compensation (SBC)'s USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Stock-Based Compensation (SBC)'s Metsera historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Cash Flow — Metsera

All Key Metrics — Metsera